PuriCore (AIM:PURI) is an emerging biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. In 2016, the Company began development of small molecule, immunomodulatory drug therapies in inflammatory diseases, with potential application in dermatology, ophthalmology and rare diseases. The Company is listed on the London Stock Exchange and is headquartered in Malvern, Pennsylvania.
PuriCore utilizes different formulations to support commercial applications in Supermarket Retail (www.steriloxfresh.com) and Health Sciences. In Supermarket Retail, our products are used by leading supermarket retailers across the United States and Canada to enhance freshness of fruit, vegetable and flower displays. In Health Sciences, we offer a wound care solution, for cleansing, debriding and moisturizing chronic and acute wounds, including diabetic ulcers and burns.
Visit us at www.puricore.com
Company Details
- Employees
- 51
- Address
- 508 Lapp Road, Malvern,pa 19355,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- puricore.com
- HQ
- Malvern, PA
Puricore Questions
Puricore's website is puricore.com
Puricore's LinkedIn profile is https://www.linkedin.com/company/puricore
Puricore has
51 employees.
View email and phone details for 51
employees at Puricore.
Puricore's industry is
Biotechnology Research
Puricore's top competitors are
Pfe Medical,
Amtech Software,
Lutze Ltd.,
Kapur Pvt Limited,
Cantel Medical,
Kapur International, Inc.,
The Davies-Woerner Group (Dwg),
Integrichain,
Visiongm,
Jankidas Kapur Public School.
Puricore's categories are Biotechnology Research
